G. Bresci et al., COLONIC DISEASE IN CIRRHOTIC-PATIENTS WITH PORTAL-HYPERTENSION - AN ENDOSCOPIC AND CLINICAL-EVALUATION, Journal of clinical gastroenterology, 26(3), 1998, pp. 222-227
Fifty cirrhotic patients with portal hypertension but without colonic
or systemic disease underwent lower gastrointestinal endoscopy in orde
r to investigate the effects, if any, of portal hypertension on the co
lon. Fifty patients without liver or systemic disease, examined by col
onoscopy because of irritable bowel syndrome in the same period served
as controls. Rectosigmoid varices were observed in 34% of the cirrhot
ic patients and 2% of the controls. Hemorrhoids were observed in 70% o
f the cirrhotic patients and 48% of the controls. Multiple vascular-ap
pearing lesions were found in 16% of the cirrhotic patients and 6% of
the controls. Nonspecific inflammatory changes were noted in 10% of th
e cirrhotic patients and 4% of the controls. Simultaneous presence, in
the same patient, of rectosigmoid varices, hemorrhoids, multiple vasc
ular-appearing lesions, and nonspecific inflammatory changes, was obse
rved in only five (10%) of the cirrhotic patients. We found polyps in
12% of the cirrhotic patients and 14% of the controls, and a malignant
tumor in 4% of the cirrhotic patients. The patients with normal colon
oscopic findings were 8% of the cirrhotic patients and 36% of the cont
rols. All patients and controls were followed up for 1 year; there was
no gastrointestinal hemorrhage among controls, whereas 34% of the cir
rhotic patients had an upper gastrointestinal hemorrhage (88% from eso
phageal varices, 12% from the stomach) and 4% had a lower gastrointest
inal hemorrhage (one from rectosigmoid varices and one from nonspecifi
c inflammatory lesions). Colonic lesions were significantly more frequ
ent in the cirrhotic patients (92%) than in the control group (64%); h
owever, such lesions did not seem specific to the disease and were not
statistically correlated with the degree of esophageal varices by Chi
ld's grading, the etiology of cirrhosis, or the bleeding risk from the
lower gastrointestinal tract.